Form 4: LeMaitre Vascular CFO Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition and disposal of company stock related to dividend equivalent rights and tax withholding.

Summary

  • On December 20, 2024, Joseph P. Pellegrino JR, the CFO of LeMaitre Vascular, engaged in transactions involving the company's common stock.
  • He acquired 17 shares of common stock upon the release of dividend equivalent rights.
  • He disposed of 169 shares to satisfy tax withholding obligations related to the vesting of restricted stock units awarded on December 20, 2019.
  • Following these transactions, Pellegrino directly owns 9,079 shares of LeMaitre Vascular common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like the CFO, who trade in their company's stock. It provides transparency to the market regarding insider activity.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they involve a small number of shares.
  • The transactions reflect the CFO's compensation and tax obligations related to company stock.

Key Dates

DateDescription
12/20/2019Date of restricted stock unit award grant.
12/20/2024Date of stock transactions: acquisition of shares from dividend equivalent rights and disposal of shares for tax withholding.
12/26/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.